RIL
TNGX icon

Rothschild Investment LLC’s Tango Therapeutics TNGX Stock Holding History

Rothschild Investment LLC’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
107
+21
+24% +$519 ﹤0.01% 2505
2026
Q1 		$1.8K Buy
86
+60
+231% +$835 ﹤0.01% 2603
2025
Q4 		$230 Buy
26
+6
+30% +$52 ﹤0.01% 3092
2025
Q3 		$168 Buy
+20
New +$135 ﹤0.01% 3023
2025
Q1 		– Sell
-40
Closed -$124 – 3090
2024
Q4 		$124 Sell
40
-55
-58% -$255 ﹤0.01% 2884
2024
Q3 		$732 Buy
95
+65
+217% +$620 ﹤0.01% 2354
2024
Q2 		$257 Buy
+30
New +$232 ﹤0.01% 2380

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Rothschild Investment LLC's TNGX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Tango Therapeutics (TNGX) stake by 24% in Q2 2026, buying an estimated $519 and bringing the position to 107 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

Rothschild Investment LLC first reported a position in TNGX in Q2 2024 and has held it in 7 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Rothschild Investment LLC held 107 shares of Tango Therapeutics worth $3.35K as of Q2 2026.
  • Rothschild Investment LLC bought 21 Tango Therapeutics shares in Q2 2026, an estimated $519.
  • Tango Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2505 holding.
  • Rothschild Investment LLC first reported a position in Tango Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.